Gao et al. evaluated the degree of BRD4 expression levels in thyroid cancers and the possibility of BRD4 inhibition for cell viability, NIS expression, and RAI uptake (Figure 3A) 186. This evidence concerns the gene SLC5A5 and thyroid cancer.